Ana Sampedro

879 total citations
27 papers, 387 citations indexed

About

Ana Sampedro is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Genetics. According to data from OpenAlex, Ana Sampedro has authored 27 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 10 papers in Pediatrics, Perinatology and Child Health and 5 papers in Genetics. Recurrent topics in Ana Sampedro's work include Porphyrin Metabolism and Disorders (19 papers), Heme Oxygenase-1 and Carbon Monoxide (16 papers) and Neonatal Health and Biochemistry (10 papers). Ana Sampedro is often cited by papers focused on Porphyrin Metabolism and Disorders (19 papers), Heme Oxygenase-1 and Carbon Monoxide (16 papers) and Neonatal Health and Biochemistry (10 papers). Ana Sampedro collaborates with scholars based in Spain, United States and Sweden. Ana Sampedro's co-authors include Antonio Fontanellas, Rafael Enrı́quez de Salamanca, Carmen Unzu, Jesús Prìeto, Itsaso Mauleón, Ignacio Melero, Pedro Berraondo, Harald Petry, Stuart G. Beattie and Sandra Hervás‐Stubbs and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Human Molecular Genetics.

In The Last Decade

Ana Sampedro

27 papers receiving 384 citations

Peers

Countries citing papers authored by Ana Sampedro

Since Specialization

Citations

This map shows the geographic impact of Ana Sampedro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Sampedro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Sampedro more than expected).

Fields of papers citing papers by Ana Sampedro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Sampedro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Sampedro. The network helps show where Ana Sampedro may publish in the future.

Co-authorship network of co-authors of Ana Sampedro

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Sampedro. A scholar is included among the top collaborators of Ana Sampedro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Sampedro. Ana Sampedro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nutritional Interventions with Bacillus coagulans Improved Glucose Metabolism and Hyperinsulinemia in Mice with Acute Intermittent Porphyria 2023 ·International Journal of Molecular Sciences ·Miriam Longo, (unknown), (unknown), José Ignacio Riezu‐Boj, Raquel Urtasun, (unknown), Ana Sampedro, María Collantes, Iván Peñuelas, María J. Moreno‐Aliaga, Matías A. Ávila, Elena Di Pierro, Miguel Barajas, Fermı́n I. Milagro, Paola Dongiovanni, Antonio Fontanellas	2
2	Recent Insights into the Pathogenesis of Acute Porphyria Attacks and Increasing Hepatic PBGD as an Etiological Treatment 2022 ·Life ·(unknown), (unknown), Ana Sampedro, Lei Jiang, Gilles Joucla, (unknown), José L. Lanciego, Paolo G.V. Martini, Pedro Berraondo, Matías A. Ávila, Antonio Fontanellas	12
3	Recombinant porphobilinogen deaminase targeted to the liver corrects enzymopenia in a mouse model of acute intermittent porphyria 2022 ·Science Translational Medicine ·(unknown), (unknown), (unknown), María Merino, Lei Jiang, Ana Sampedro, Manuel Alegre, Fernando J. Corrales, Marı́a J. Garrido, Paolo G.V. Martini, José L. Lanciego, Jesús Prìeto, Pedro Berraondo, Antonio Fontanellas	12
4	Messenger RNA as a personalized therapy: The moment of truth for rare metabolic diseases 2022 ·International review of cell and molecular biology ·(unknown), (unknown), Ana Sampedro, Lei Jiang, María J. Iraburu, Paolo G.V. Martini, Pedro Berraondo, Matías A. Ávila, Antonio Fontanellas	8
5	Computational disease model of phenobarbital-induced acute attacks in an acute intermittent porphyria mouse model 2018 ·Molecular Genetics and Metabolism ·(unknown), (unknown), Ana Sampedro, (unknown), Iñaki F. Trocóniz, Antonio Fontanellas, Zinnia P. Parra‐Guillén	2
6	Glucose metabolism during fasting is altered in experimental porphobilinogen deaminase deficiency 2016 ·Human Molecular Genetics ·María Collantes, (unknown), Marina Benito, (unknown), Mercedes Delgado, María Vinaixa, Ana Sampedro, Rafael Enrı́quez de Salamanca, Elena Prieto, Miguel A. Pozo, Iván Peñuelas, Fernando J. Corrales, Miguel Barajas, Antonio Fontanellas	22
7	Vitamin D-binding protein as a biomarker of active disease in acute intermittent porphyria 2015 ·Journal of Proteomics ·(unknown), Ana Sampedro, María I. Mora, Itsaso Mauleón, Víctor Segura, Rafael Enrı́quez de Salamanca, Pauline Harper, Eliane Sardh, Fernando J. Corrales, Antonio Fontanellas	2
8	Helper-dependent adenovirus achieve more efficient and persistent liver transgene expression in non-human primates under immunosuppression 2015 ·Gene Therapy ·Carmen Unzu, Ignacio Melero, Sandra Hervás‐Stubbs, Ana Sampedro, Uxua Mancheño, Aizea Morales‐Kastresana, (unknown), Rafael Enrı́quez de Salamanca, Alberto Benito, Antonio Fontanellas	13
9	Innate Functions of Immunoglobulin M Lessen Liver Gene Transfer with Helper-Dependent Adenovirus 2014 ·PLoS ONE ·Carmen Unzu, Ignacio Melero, Aizea Morales‐Kastresana, Ana Sampedro, (unknown), Arantza Azpilikueta, María C. Ochoa, Juan Dubrot, Eduardo Martínez‐Ansó, Antonio Fontanellas	7
10	Ocular Pain After Intravitreal Injection 2013 ·Current Eye Research ·María R. Sanabria, Javier A. Montero, (unknown), (unknown), Alicia Galindo‐Ferreiro, Itziar Fernández, Rosa M. Coco, Ana Sampedro	33
11	Helper-dependent adenoviral liver gene therapy protects against induced attacks and corrects protein folding stress in acute intermittent porphyria mice 2013 ·Human Molecular Genetics ·Carmen Unzu, Ana Sampedro, Itsaso Mauleón, Manuela González-Aparicio, Rafael Enrı́quez de Salamanca, Jesús Prìeto, Tomás Aragón, Antonio Fontanellas	18
12	Transient and intensive pharmacological immunosuppression fails to improve AAV-based liver gene transfer in non-human primates 2012 ·Journal of Translational Medicine ·Carmen Unzu, Sandra Hervás‐Stubbs, Ana Sampedro, Itsaso Mauleón, Uxua Mancheño, Carlos Alfaro, Rafael Enrı́quez de Salamanca, Alberto Benito, Stuart G. Beattie, Harald Petry, Jesús Prìeto, Ignacio Melero, Antonio Fontanellas	56
13	Renal Failure Affects the Enzymatic Activities of the Three First Steps in Hepatic Heme Biosynthesis in the Acute Intermittent Porphyria Mouse 2012 ·PLoS ONE ·Carmen Unzu, Ana Sampedro, Eliane Sardh, Itsaso Mauleón, Rafael Enrı́quez de Salamanca, Jesús Prìeto, Eduardo Salido, Pauline Harper, Antonio Fontanellas	15
14	Intensive Pharmacological Immunosuppression Allows for Repetitive Liver Gene Transfer With Recombinant Adenovirus in Nonhuman Primates 2010 ·Molecular Therapy ·Antonio Fontanellas, Sandra Hervás‐Stubbs, Itsaso Mauleón, Juan Dubrot, Uxua Mancheño, María Collantes, Ana Sampedro, Carmen Unzu, Carlos Alfaro, Asís Palazón, Cristian Smerdou, Alberto Benito, Jesús Prìeto, Iván Peñuelas, Ignacio Melero	24
15	Sustained Enzymatic Correction by rAAV-Mediated Liver Gene Therapy Protects Against Induced Motor Neuropathy in Acute Porphyria Mice 2010 ·Molecular Therapy ·Carmen Unzu, Ana Sampedro, Itsaso Mauleón, Manuel Alegre, Stuart G. Beattie, Rafael Enrı́quez de Salamanca, Jolanda Snapper, Jaap Twisk, Harald Petry, Gloria González‐Aseguinolaza, Julio Artieda, Maria Sol Rodríguez-Peña, Jesús Prìeto, Antonio Fontanellas	50
16	Epidermal growth factor receptor ligands in murine models for erythropoietic protoporphyria: potential novel players in the progression of liver injury. 2009 ·PubMed ·Carmen Berasain, Ana Sampedro, Itsaso Mauleón, Saioa Goñi, María U. Latasa, (unknown), María García‐Bravo, Carmen Unzu, Fernando J. Corrales, Rafael Enrı́quez de Salamanca, Jesús Prìeto, Matías A. Ávila, Antonio Fontanellas	4
17	Induction of hepatic aminolevulinate acid synthetase activity by isoflurane in a genetic model for erythropoietic protoporphyria. 2009 ·PubMed ·(unknown), María‐Josefa Morán‐Jiménez, María García‐Bravo, Ana Sampedro, Alcira Batlle, Rafael Enrı́quez de Salamanca, Antonio Fontanellas	1
18	Porphobilinogen deaminase over-expression in hepatocytes, but not in erythrocytes, prevents accumulation of toxic porphyrin precursors in a mouse model of acute intermittent porphyria 2009 ·Journal of Hepatology ·Carmen Unzu, Ana Sampedro, Itsaso Mauleón, Lucía Vanrell, Juan Dubrot, Rafael Enrı́quez de Salamanca, Gloria González‐Aseguinolaza, Ignacio Melero, Jesús Prìeto, Antonio Fontanellas	23
19	PET imaging of thymidine kinase gene expression in the liver of non-human primates following systemic delivery of an adenoviral vector 2008 ·Gene Therapy ·Antonio Fontanellas, Sandra Hervás‐Stubbs, Ana Sampedro, María Collantes, (unknown), Itsaso Mauleón, Astrid Pañeda, Gemma Quincoces, Jesús Prìeto, Ignacio Melero, Iván Peñuelas	12
20	[Asthma and hyperthyroidism: a dangerous association]. 1990 ·PubMed ·(unknown), (unknown), (unknown), Ana Sampedro	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact